The
Spanish Agency for Medicines and Health Products
(
AEMPS
), dependent on the
Ministry of Health
, has withdrawn several batches of presentations of the drugs
Diosmina
and
Flebicorn
, both from the company
Kern Pharma
, due to the "detection of an impurity above its limit settled down".
Both are
venotonic drugs
, that is, they increase the tone of the veins and the resistance of the capillaries (small blood vessels).
You can check here the lots withdrawn.
In adults, they are indicated for the relief of symptoms related to mild venous insufficiency of the lower extremities, such as pain, a sensation of heaviness, tightness, tingling and itching in legs with varicose veins or swollen legs.
Given the detection of the impurity, Health has decided to withdraw from the market all the units distributed from the affected batches and return them to the laboratory through the usual channels.
Conforms to The Trust Project criteria
Know more
HealthPatients with previous corticosteroid treatment hospitalized with Covid have a worse prognosis
Coronavirus The WHO warns that the endemic is not the solution to Covid: "It only means that it will be here forever"
Health The rate of deaths from Covid is up to 48 times lower with the third dose than without the vaccine
See links of interest
Last News
covid
Ukraine
Work calendar 2022
The reading
esther lopez
Athletic Club - Espanyol